Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 3rd Quarter - Report

DISPOSERX

via FROST BROWN TODD LLC

3rd Quarter (July 1 - Sep 30) · 2023Posted Oct 6, 2023Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: DISPOSERX
Description: medication management company
Location: North Carolina · United States of America

Registrant

Firm: FROST BROWN TODD LLC
Description: law firm
Location: Lexington, Kentucky, United States of America

Lobbying activities

1 issue

Pharmacy
Support Act
LobbyistsJONATHAN MILLER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

DISPOSERX — Lobbying — Receipts Report